BOSTON, MA – Federal health officials have issued an urgent recall of infant formula after cases of botulism were reported in 10 states, prompting warnings to parents and caregivers to immediately stop using affected products.
The recall affects specific lots of infant formula that have been linked to cases of infant botulism, a rare but potentially fatal illness caused by toxins produced by Clostridium botulinum bacteria. The contaminated formula has been associated with illness in multiple infants across the United States.
Infant botulism occurs when babies ingest spores of the botulism bacteria, which then grow in the intestines and produce dangerous toxins. Symptoms can include constipation, weak cry, poor feeding, drooping eyelids, loss of head control, and difficulty breathing. The illness can progress rapidly and requires immediate medical attention.
Parents and caregivers are urged to check their formula supplies against the recall list and dispose of any affected products immediately. Retailers have been instructed to remove the recalled formula from shelves and provide refunds to customers who purchased the contaminated products.
The 10 states reporting cases have not all been publicly identified, though health officials confirmed that Massachusetts is among the affected areas. The Food and Drug Administration and Centers for Disease Control and Prevention are working with state health departments to track additional cases and prevent further illnesses.
Health officials are also investigating whether the contamination occurred during manufacturing, packaging, or distribution. Formula manufacturers are required to follow strict safety protocols to prevent bacterial contamination, and the recall suggests a significant breakdown in quality control procedures.
Any infant who consumed the recalled formula and is showing symptoms should receive immediate medical evaluation. Infant botulism is treatable with an antitoxin medication called BabyBIG (Botulism Immune Globulin Intravenous), which is most effective when administered early in the course of illness.
The recall comes at a time when formula supplies remain tight in some areas following previous production disruptions and recalls. Parents struggling to find alternative formula should contact their pediatricians for guidance on safe feeding options.
Federal investigators are conducting a full review of the manufacturing facility where the contaminated formula was produced. Additional recalls may be issued if investigators determine that other product lots pose a risk to infants.
The FDA has established a hotline for parents with questions about the recall and is providing updated information on its website as the investigation continues. Healthcare providers have been alerted to watch for additional cases of infant botulism and report suspected cases to public health authorities.
Infant botulism cases typically occur when babies consume honey, which can contain botulism spores, or through environmental exposure to contaminated soil or dust. Contamination of commercial formula is extremely rare, making this recall particularly concerning for health officials.
The investigation is ongoing, and officials expect to release additional information about the scope of the contamination and the number of affected infants as their review progresses.
